Oesophageal cancer Q&A with Professor Jeff Evans

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

Length: 06:12

Professor Jeff Evans, a Medical Oncologist based at the University of Glasgow and the Beatson West of Scotland Cancer Centre in Glasgow, takes part in an oesophageal Q&A. Within the recording he discusses a global overview of the epidemiology of oesophageal cancer, the risk factors, what is typically seen when patients present with oesophageal cancer, challenges in diagnosing, advice when treating advanced oesophageal cancer, how treatment of patients is changing, challenges of treating and key learnings from the implementation of immunotherapy.

More information about KEYTRUDA® (pembrolizumab) in locally advanced unresectable or metastatic oesophageal cancer

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) 
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website